
Brevel
AgriTech & FoodTechBrevel develops alternative protein from microalgae using a process that combines fermentation and light.
Introduce me to Brevel
Image source: company website sharing image
Founders & company facts
Sources reviewed:Reported cumulative funding
$35,900,000 · Source
This index includes companies with publicly reported total funding up to US$150 million. This is a reported total, not valuation, the latest round size or confirmation of an open round. Funding reviewed: .
Documented founding team
- Yonatan GolanSource: Yonatan Golan
- Matan GolanSource: Matan Golan
- Ido GolanSource: Ido Golan
- Founded
- 2017Source
- Reported Israeli location
- Kiryat GatSource
- Team range in directory
- 11-50Source
- Reported business model
- B2B, B2B2CSource
Selected disclosed financing
Selected transactions, with dates, funding types and reported participants.
- May 2026$1MNon-equity funding
- Mar 2025$12.5MSeedNamed participants
NevaTeam Partners · Good Protein Fund · PVS Investments · Siddhi Capital · European Union’s EIC Fund · theFoodTechLab
Source
Company overview
Product & customers
Brevel develops alternative protein from microalgae using a process that combines fermentation and light. Its ingredients target food manufacturers seeking functional protein for products such as dairy alternatives.
Commercial potential · editorial analysis
The commercial opportunity is supplying ingredients to established food brands instead of building every consumer product internally, with demand linked to formulation performance. Investors should distinguish paid use and renewals from pilots, and examine how sales and delivery costs change as deployments expand.
What to validate
Diligence should focus on production costs at commercial scale, sensory performance, regulatory clearance and binding demand rather than sample requests. Evidence should come from representative customer deployments, with costs, limitations and failure cases reported alongside successful results.
Product source reviewed on . Company source